# JC Capital

> JC Capital is a VC fund in Beijing backing Health Care and Medical. See 41 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 41
- Last investment: Aug 2026
- Lead investor: 37%
- Last updated: Aug 2026
- Website: http://www.jkjccapital.com/

JC Capital is a venture capital institution specialized in early and mid-term technology investment.

## Contacts

5 contacts available for JC Capital. Shizune tracks 2 team members at JC Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/jc-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $98k–$5.7M |
| Series A | $1.4M–$15M |
| Series B | $2.8M–$14M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 22% |
| Medical | 6 | 15% |
| Biotechnology | 6 | 15% |
| Internet | 5 | 12% |
| Software | 5 | 12% |

60 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 22 | 54% |
| Series B | 6 | 15% |
| Seed | 5 | 12% |
| Angel | 5 | 12% |
| Series C | 1 | 2% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 36 | 88% |
| Vietnam | 1 | 2% |
| Philippines | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Sun Zhixing | Executive Director | 1 | https://shizune.co/investors/profile/sun-zhixing |
| Xianyue Guǎn | Founding Partner | 0 | https://shizune.co/investors/profile/xianyue-gu%C7%8En |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Guangna Development | Guangna Siwei is an optoelectronic device seller. | $29.6M | Venture - Series Unknown | Aug 05, 2026 |  |
| Giant Microbiology | Giant Microbiology is a company that produces synthetic biological raw materials in an environmentally friendly manner for the fields of beauty and daily chemicals, functional foods, and medical beauty.. The business focuses on creating "high-gross-profit innovative products" that satisfy consumer demand and offer useful, cutting-edge rawmaterial solutions, with bioactive sugars serving as its starting point. Hyaluronic acid, oligosaccharides, and functional oligosaccharides are among the goods it primarily develops and produces. |  | Series A | Nov 26, 2025 |  |
| Guangna Anliao | Guangna Anliao is a forward-looking technology company dedicated to the research, development, and innovation of advanced medical devices. The company focuses on creating high-quality, reliable solutions that support modern healthcare needs, with an emphasis on improving patient outcomes, enhancing clinical efficiency, and driving technologicalprogress in the medical field. |  | Series A | Sep 30, 2025 |  |
| Xunsheng Medical | Xunsheng Medical is a biotechnology business that focuses on the research and development of tumor immunotherapy medications. |  | Series A | Aug 18, 2025 |  |
| Zhizhen Precision | Zhizhen Precision is a high-end integrated circuit test equipment developer. |  | Series A | Nov 17, 2023 |  |
| Sietium | Sietium is a high-tech company that independently designs and develops GPU chips and GPU solutions. | $14.5M | Series A | Apr 18, 2023 |  |
| Dragonfly Automation Software | Dragonfly Automation Software provides management and control system product solutions for customers in aerospace, machinery manufacturing, factory automation, and high-end precision instruments. | $12.9M | Series A | Dec 16, 2022 |  |
| Jingda Bio | Jingda Bio is a biological cell drug developer dedicated to the research and development of general-purpose NK/CAR-NK cell drugs. |  | Seed | Jun 21, 2022 |  |
| Phenomenon Array | Phenomenon Array is ​​a computer system developer, dedicated to FPGA-based replacement of CPU for storage and computing. |  | Series A | May 12, 2022 |  |
| Fino Gate | Fino Gate is a project-construction company. Non-von Neumann general-purpose network computing system that is autonomous and controllable. concentrates on developing a new generation of controllable computer systems. Empower the computing power infrastructure represented by data centers and intelligent computing centers, as well as 5G, artificialintelligence, cloud computing, blockchain, and industrial IoT, through edge computing equipment, edge cloud, an AI middle platform, and four-tier products for vertical industry applications. The development of the Internet's new technological infrastructure can be used in the areas of intelligent security, transportation, and water conservation. |  | Series A | May 12, 2022 |  |

10 of 41 investments shown.

## Co-investors
- [Addor Capital](https://shizune.co/investors/profile/addor-capital) — VC Fund, 3 deals together
- [Legend Star](https://shizune.co/investors/profile/legendstar) — VC Fund, 3 deals together
- [Baopu Asset Management](https://shizune.co/investors/profile/baopu-asset-management) — VC Fund, 2 deals together
- [Beijing Science & Technology Innovation Investment Management](https://shizune.co/investors/profile/beijing-science-technology-innovation-investment-management) — VC Fund, 2 deals together
- [Beijing TRS Information Technology](https://shizune.co/investors/profile/beijing-trs-information-technology-co-ltd) — VC Fund, 2 deals together
- [China Biotech](https://shizune.co/investors/profile/china-biotech) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Warner Music Group](https://shizune.co/investors/profile/warner-music-group) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Goodwater Capital](https://shizune.co/investors/profile/goodwater-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Local Investors in Asia](https://shizune.co/investors/local-investors-asia)
- [Local VC Funds in Asia](https://shizune.co/investors/local-vc-funds-asia)
- [Local Investors in China](https://shizune.co/investors/local-investors-china)
- [Travel Investors in China](https://shizune.co/investors/travel-investors-china)
- [Travel VC Funds in China](https://shizune.co/investors/travel-vc-funds-china)
- [SaaS Investors in Philippines](https://shizune.co/investors/saas-investors-philippines)

## FAQ

### What does JC Capital invest in?

JC Capital invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series B stage. Most of the 41 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is JC Capital's check size?

JC Capital typically joins rounds of $98k–$5.7M at Seed, $1.4M–$15M at Series A and $2.8M–$14M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds JC Capital participates in.

### How do I contact JC Capital?

Public channels for JC Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at JC Capital?

The team at JC Capital includes Sun Zhixing (Executive Director) and Xianyue Guǎn (Founding Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co